AnaptysBio, Inc. (ANAB)
58.88
+7.61
(+14.84%)
USD |
NASDAQ |
Apr 24, 16:00
59.02
+0.14
(+0.24%)
After-Hours: 20:00
AnaptysBio Total Liabilities (Quarterly) : 327.18M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 161.76M |
| ADMA Biologics, Inc. | 156.03M |
| Nektar Therapeutics | 190.57M |
| Rigel Pharmaceuticals, Inc. | 169.14M |
| Axsome Therapeutics, Inc. | 601.51M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 364.40M |
| Shareholders Equity (Quarterly) | 37.21M |
| Debt to Equity Ratio | 7.811 |
| Current Ratio | 9.068 |
| Net Debt Paydown Yield | 1.69% |